Prioritizing the scale-up of interventions for malaria control and elimination
暂无分享,去创建一个
Peter Winskill | Patrick G Walker | Richard E Cibulskis | Azra C Ghani | P. Winskill | P. Walker | A. Ghani | R. Cibulskis
[1] Yuming Guo,et al. The effect of air pollution on human physiological function in China: a longitudinal study , 2015, The Lancet.
[2] P. Winskill,et al. Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa , 2017, BMJ Global Health.
[3] S. C. T. P. Rts. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial , 2015, The Lancet.
[4] Joseph Keating,et al. Strategic roles for behaviour change communication in a changing malaria landscape , 2014, Malaria Journal.
[5] M. Tanner,et al. The Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants in Sub-Saharan Africa , 2010, PloS one.
[6] A. Ramsay,et al. The need for operational research and capacity-building in support of the Global Technical Strategy for Malaria 2016–2030 , 2016, Malaria Journal.
[7] J. Skordis-Worrall,et al. Cost and cost effectiveness of long-lasting insecticide-treated bed nets - a model-based analysis , 2012, Cost Effectiveness and Resource Allocation.
[8] C. Menéndez,et al. Cost-Effectiveness of Intermittent Preventive Treatment of Malaria in Pregnancy in Southern Mozambique , 2010, PloS one.
[9] 王德伦. 英语-翻译-Internet , 2000 .
[10] Gao Qi,et al. Global technical strategy for malaria 2016–2030 , 2015 .
[11] A. Ghani,et al. Costs and cost-effectiveness of malaria control interventions - a systematic review , 2011, Malaria Journal.
[12] Samir Bhatt,et al. Coverage and system efficiencies of insecticide-treated nets in Africa from 2000 to 2017 , 2015, eLife.
[13] S. Bhatt,et al. Global investment targets for malaria control and elimination between 2016 and 2030 , 2017, BMJ Global Health.
[14] Caroline W. Kabaria,et al. A global map of dominant malaria vectors , 2012, Parasites & Vectors.
[15] Samir Bhatt,et al. Quantifying the contribution of Plasmodium falciparum malaria to febrile illness amongst African children , 2017, eLife.
[16] Peter G. Kremsner,et al. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. , 2015 .
[17] Neil M Ferguson,et al. Modelling the impact of vector control interventions on Anopheles gambiae population dynamics , 2011, Parasites & Vectors.
[18] P. Walker,et al. Estimating the most efficient allocation of interventions to achieve reductions in Plasmodium falciparum malaria burden and transmission in Africa: a modelling study. , 2016, The Lancet. Global health.
[19] A. Ghani,et al. Gradual acquisition of immunity to severe malaria with increasing exposure , 2015, Proceedings of the Royal Society B: Biological Sciences.
[20] M. Aikins,et al. Cost-effectiveness of seasonal malaria chemoprevention in upper west region of Ghana , 2016, Malaria Journal.
[21] F. Tediosi,et al. Costing RTS,S introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: A generalizable approach drawing on publicly available data , 2015, Vaccine.
[22] Thomas A. Smith,et al. Determinants of the Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants and Children , 2011, PloS one.
[23] P. Gething,et al. Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa, 2003–2015: a modelling study using data from national surveys , 2017, The Lancet. Global health.
[24] B. Hamainza,et al. Relative costs and effectiveness of treating uncomplicated malaria in two rural districts in Zambia: implications for nationwide scale-up of home-based management , 2011, Malaria Journal.
[25] J. Birt,et al. Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review , 2012, Cost Effectiveness and Resource Allocation.
[26] P. Gething,et al. Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study. , 2016, The Lancet. Infectious diseases.
[27] Hannah C. Slater,et al. The US President's Malaria Initiative, Plasmodium falciparum transmission and mortality: A modelling study , 2017, PLoS medicine.
[28] Katya Galactionova,et al. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models , 2016, The Lancet.
[29] T. Edejer,et al. Disease control programme support costs: an update of WHO-CHOICE methodology, price databases and quantity assumptions , 2017, Cost Effectiveness and Resource Allocation.
[30] Wes Hinsley,et al. Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies , 2010, PLoS medicine.
[31] Neil M. Ferguson,et al. Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa , 2014, Nature Communications.